Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Response and Impact on Safety, Adherece Anc Persistent During Treatment in an Observational Trial for the Evaluation of the Long-term Effectiveness of Bulevirtide in Patients With Chronic Delta Hepatitis: the ARISTOTELE Study

NCT07116044 is registered in ClinicalTrials.gov with University of Molise as lead sponsor.

NCT NCT07116044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Response and Impact on Safety, Adherece Anc Persistent During Treatment in an Observational Trial for the Evaluation of the Long-term Effectiveness of Bulevirtide in Patients With Chronic Delta Hepatitis: the ARISTOTELE Study
Lead sponsor
University of Molise
Phase
Observational
Overall status
Completed
Start date
June 15, 2023
Completion date
July 30, 2025
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate response to treatment both biochemically and virologically to determine the safety and effectiveness of bulevirtide therapy in hdv patients